News

17
May

Genoskin recrute un Responsable R&D et Innovation

Genoskin recruiting for Skin Immunotoxicology R&D and Innovation Manager Who we are: Genoskin (genoskin.com) is a biotechnology company that was created in 2011. The company is based in Toulouse (France) and also has an office in Salem, MA (Boston area, USA). Genoskin is a leader and pioneer in standardized human skin biopsies for ex vivo clinical testing. Thanks to a patented

Read more

8
May

SID2019: Preserving skin integrity and metabolism

SID2019: Genoskin validates skin integrity and metabolism at 10 days with Promega Glucose-Glo™ and Lac­tate-Glo™ Assays Genoskin’s team of skin experts will be presenting its latest work at the 77th SID Annual Meeting from May 8 to May 11 in Chicago. To learn more about our live human skin models and R&D services, swing by booth #106. Our Chief Commercial
Read more
29
Apr

Come and meet the team at SID2019 in Chicago

Genoskin to attend the 77th Annual Meeting of the Society for Investigative Dermatology  The 77th Annual Meeting of the Society for Investigative Dermatology (SID2019) is a knowledge hub that connects a diverse group of senior researchers, clinicians and clinical trainees. The SID Meeting appears as a premier forum for the exchange of knowledge in various disciplines, from Dermatology and Immunology
Read more
23
Apr

We are hiring! Come join our growing US Business Development team!

We are hiring! Come join our growing US Business Development team! Who we are: Genoskin (genoskin.com) is a biotechnology company started in 2011. The company has offices and labs in Toulouse (France) and Boston area (USA). We are experts in human skin. We develop and commercialize ready-to-use, standardized ex vivo human skin models testing kits with live human skin. Our products

Read more

22
Apr

HypoSkin® presented at New Frontiers in 3D in Cambridge, MA

Genoskin presents its subcutaneous injection model HypoSkin® at New Frontiers in 3D Genoskin’s CEO Pascal Descargues, PhD will attend scientific symposium New Frontiers in 3D at the MIT Samberg Center in Cambridge, MA, USA. Take the opportunity to discover our unique subcutaneous injection model through a poster presentation.   Hyposkin®, a unique human skin model to study subcutaneous injection Poster
Read more
7
Mar

Unique subcutaneous injection model at SOT meeting in Baltimore

Genoskin presents unique subcutaneous injection model at SOT Baltimore The Genoskin team spreads its wings: in March, you'll find us at the Society of Toxicology's Annual Meeting in Baltimore, US, where we'll present our new HypoSkin model to test the efficacy and toxicity of subcutaneous injections on live human skin models.   Unique tools to test human skin response to all
Read more